Clinical Trial Update: Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on once-daily versus twice-daily immunosuppressant regimens for renal transplant adherence, with status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Transplant Rejection Prevention

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Adherence to Medication Regime | Phase 4 | Status: UNKNOWN